cypermethrin
Small moleculeexperimental
Clinical trial activity
2 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Oct 17, 2020 (NCT04566510)
Timeline
No events for the selected filters.
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- cypermethrin
- cypermethrin
- cypermethrin
- cypermethrin
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05796193 | N/A | Jul 31, 2023 | Institut Pierre Richet, University of London, University of Nevada, Las Vegas, University of Ottawa |
| NCT04566510 | N/A | Oct 17, 2020 | National Institute of Allergy and Infectious Diseases (NIAID), University of California, San Francisco, University of London |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of London | Academic/Hospital | 2 | 1 | 1 | 2020 |
| Institut Pierre Richet | Academic/Hospital | 1 | 0 | 1 | 2023 |
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 1 | 0 | 1 | 2020 |
| University of California, San Francisco | Academic/Hospital | 1 | 1 | 1 | 2020 |
| University of Nevada, Las Vegas | Academic/Hospital | 1 | 0 | 1 | 2023 |
| University of Ottawa | Academic/Hospital | 1 | 0 | 1 | 2023 |
6 organizations
Page 1 / 1